Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer

被引：0
|
作者：
Shari B. Goldfarb
Volkan Turan
Giuliano Bedoschi
Enes Taylan
Nadia Abdo
Tessa Cigler
Heejung Bang
Sujita Patil
Maura N. Dickler
Kutluk H. Oktay
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Obstetrics and Gynecology and Reproductive Sciences
[2] Weill Cornell Medical Center,Department of Obstetrics and Gynecology
[3] Yale University School of Medicine,Department of Obstetrics and Gynecology
[4] Health and Technology University School of Medicine,Division of Biostatistics, Department of Public Health Sciences
[5] Ribeirao Preto School of Medicine,undefined
[6] University of Sao Paulo,undefined
[7] University of California,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 185卷
关键词：
Drug therapy; Breast neoplasms; Anti-mullerian hormone; Fertility preservation; Ovarian reserve;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：165 / 173
页数：8
相关论文
共 50 条
  • [21] Impact of breast cancer chemotherapy on ovarian reserve: A prospective analysis by menstrual history and ovarian reserve markers.
    Reh, A. E.
    Oktem, O.
    Lostritto, K.
    Oktay, K.
    FERTILITY AND STERILITY, 2006, 86 : S97 - S98
  • [22] Is tamoxifen alone adequate therapy in very young Chinese women with operable breast cancer?
    Wang, S.
    Yang, Hua
    Ou, Wei
    Sun, Haibo
    Fang, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer
    Lambertini, Matteo
    Ceppi, Marcello
    Anderson, Richard A.
    Cameron, David A.
    Bruzzone, Marco
    Franzoi, Maria Alice
    Massarotti, Claudia
    El-Abed, Sarra
    Wang, Yingbo
    Lecocq, Christophe
    Nuciforo, Paolo
    Rolyance, Rebecca
    Pusztai, Lajos
    Sohn, Joohyuk
    Latocca, Maria Maddalena
    Arecco, Luca
    Pistilli, Barbara
    Ruddy, Kathryn J.
    Ballestrero, Alberto
    Del Mastro, Lucia
    Peccatori, Fedro A.
    Partridge, Ann H.
    Saura, Cristina
    Untch, Michael
    Piccart, Martine
    Di Cosimo, Serena
    de Azambuja, Evandro
    Demeestere, Isabelle
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01): : 33 - +
  • [24] The impact of adjuvant chemotherapy on quality of life in women with early breast cancer
    Bulotiene, G.
    Ostapenko, V.
    BREAST, 2009, 18 : S69 - S69
  • [25] Systematic evaluation of ovarian reserve in young breast cancer patients treated by sequential chemotherapy
    Mailliez, A.
    Pigny, P.
    Bogart, E.
    Diomande, S.
    Tiotsia, H. Jeazet
    Bonneterre, J.
    Le Deley, M. C.
    Decanter, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [26] Combining and sequencing adjuvant chemotherapy and tamoxifen in postmenopausal women with node-positive breast cancer
    Leeper, Alexander
    Dixon, J. Michael
    WOMENS HEALTH, 2010, 6 (03) : 357 - 360
  • [27] CARCINOMA OF THE BREAST - ADJUVANT TAMOXIFEN AND CHEMOTHERAPY
    STEWART, HJ
    BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (699): : 307 - 307
  • [28] Ovarian reserve in premenopausal women with breast cancer
    Zong, Xiangyun
    Yu, Yang
    Chen, Wenhu
    Zong, Weiwei
    Yang, Hongjian
    Chen, Xuan
    BREAST, 2022, 64 : 143 - 150
  • [29] The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) women.
    Baum, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 210 - 210
  • [30] Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial
    Fallowfield, L
    Cella, D
    Cuzick, L
    Francis, S
    Locker, G
    Howell, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4261 - 4271
12345